ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Silvr, it appears that as late as April 18, 2022, Dentons was still ANIP's IP law firm,
as disclosed in the Attorney/Correspondence Information section of the Status tab of the Cortrophin trademark.

Cortrophin Trademark

Citizens Bank assigning the female testosterone patent related IP back to ANIP instead of Truist on November 19, 2021 and to have Patrice P. Jean, Chair of Hughes Hubbard & Reed LLP's Life Sciences Group act as correspondent for the four related patent applications is further evidence of a deal for female testosterone having been consummated.

Patrice P. Jeane

Hughes Hubbard and Reed LLP served as legal advisor to, but did not represent, ANI Pharmaceuticals in the acquisition of Novitium Pharma. It looks like Merck, who they have represented, is the conflict of interest preventing them from representing ANIP in a deal.

Seeing how volatile ANIP's PPS is on low trading volumes, it will be interesting see how fast it climbs when an announcement is finally made.

GLTA